Respectfully please read my post again as that’s not at all what...

Respectfully please read my post again as that’s not at all what I was suggesting nor what I said. A deal with China, or whoever it is, doesn’t mean you have to walk away as you suggest. I think China is a good option based on Pete’s comments of them doing deals more aggressively than their peers and also how interested they are in FTO. Just because we’ve got a new shiny formulation on the way doesn’t mean another party wouldn’t be interested in 110 if there’s data to support what they’re researching.

It’s been made clear that we have a buying problem, and that’s still a work in progress. Licensing now and creating a revenue stream will have a triple threat effect
-external validation
-bringing bucks in (less dilution)
-new buyers and interest (SP heading north)

the current landscape as I see it, while there’s heavy selling we’re all getting reamed regardless, we need to show something otherwise that pesky 50c could very well become a reality before we start dosing and getting hard evidence on what rc220 can do.